-transparent.png){kind=logo}
OBJECTIVE To evaluate neuroleptic dosing patterns in individuals with schizophrenia over a 10-year interval. METHODS Changes in neuroleptic dosing between 1980 and 1990 were followed in 65 patients with a diagnosis of chronic schizophrenia. RESULTS According to more recent dosing guidelines, doses were already high at the time of initial evaluation, yet overall they continued to increase during the next decade of treatment for both males and females. Patients were almost equally divided, however, by those who underwent an increase (n = 33) and those whose dose remained stable (n = 4) or was decreased (n = 28). CONCLUSIONS A considerable number of patients with schizophrenia appear to receive progressively higher neuroleptic doses over the course of their illness, despite a lack of empirical data to support such an approach. Results are discussed in terms of current dosing recommendations and factors influencing dose changes.
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
May 1967,
Thorax,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
October 2016,
Nordic journal of psychiatry,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
July 1949,
The Medical journal of Australia,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
January 1987,
Clinical and experimental rheumatology,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
April 2005,
CNS spectrums,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
September 1986,
The Ceylon medical journal,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
September 2001,
Medicina clinica,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
February 2020,
BMC psychiatry,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
August 2016,
Acta ophthalmologica,
G J Remington, and
P Prendergast, and
K Z Bezchlibnyk-Butler
April 1978,
British journal of urology,
